1. Home
  2. ISPO vs RNTX Comparison

ISPO vs RNTX Comparison

Compare ISPO & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ISPO
  • RNTX
  • Stock Information
  • Founded
  • ISPO 2010
  • RNTX 2001
  • Country
  • ISPO United States
  • RNTX United States
  • Employees
  • ISPO N/A
  • RNTX N/A
  • Industry
  • ISPO Blank Checks
  • RNTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ISPO Finance
  • RNTX Health Care
  • Exchange
  • ISPO Nasdaq
  • RNTX Nasdaq
  • Market Cap
  • ISPO 53.5M
  • RNTX 44.2M
  • IPO Year
  • ISPO N/A
  • RNTX N/A
  • Fundamental
  • Price
  • ISPO $3.81
  • RNTX $1.42
  • Analyst Decision
  • ISPO
  • RNTX
  • Analyst Count
  • ISPO 0
  • RNTX 0
  • Target Price
  • ISPO N/A
  • RNTX N/A
  • AVG Volume (30 Days)
  • ISPO 20.2K
  • RNTX 26.9K
  • Earning Date
  • ISPO 05-06-2025
  • RNTX 04-07-2025
  • Dividend Yield
  • ISPO N/A
  • RNTX N/A
  • EPS Growth
  • ISPO N/A
  • RNTX N/A
  • EPS
  • ISPO N/A
  • RNTX N/A
  • Revenue
  • ISPO $279,855,000.00
  • RNTX N/A
  • Revenue This Year
  • ISPO N/A
  • RNTX N/A
  • Revenue Next Year
  • ISPO $148.70
  • RNTX N/A
  • P/E Ratio
  • ISPO N/A
  • RNTX N/A
  • Revenue Growth
  • ISPO N/A
  • RNTX N/A
  • 52 Week Low
  • ISPO $3.11
  • RNTX $1.35
  • 52 Week High
  • ISPO $9.31
  • RNTX $7.42
  • Technical
  • Relative Strength Index (RSI)
  • ISPO 41.90
  • RNTX N/A
  • Support Level
  • ISPO $3.75
  • RNTX N/A
  • Resistance Level
  • ISPO $4.27
  • RNTX N/A
  • Average True Range (ATR)
  • ISPO 0.39
  • RNTX 0.00
  • MACD
  • ISPO -0.04
  • RNTX 0.00
  • Stochastic Oscillator
  • ISPO 17.36
  • RNTX 0.00

About ISPO Inspirato Incorporated

Inspirato Inc is a luxury travel subscription luxury travel company that provides exclusive access to a managed and controlled portfolio of curated vacation options, delivered through a model designed to ensure the service, certainty, and value that discerning customers demand. The Inspirato portfolio includes branded luxury vacation homes, accommodations at five-star hotel and resort partners, and custom travel experiences. It has a geographic location in the United States and Outside the United States. It generates the majority of its revenue from the United States.

About RNTX Rein Therapeutics Inc. Common Stock

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.

Share on Social Networks: